Page 4 - Human Challenge Programme News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Findings from the UK's world-leading human challenge study provide new insights into mild infections with SARS-CoV-2 in healthy young adults.

Open Orphan data shows SARS-CoV-2 human challenge studies safe in healthy young adults

Investegate announcements from Open Orphan PLC, Exercise of Warrants

  Open Orphan plc  (London and Euronext: ORPH) is a rapidly growing pharmaceutical service/contract research company that is a world leader in testing vaccines and antivirals using human challenge clinical trials. The company provides services to Big Pharma, biotech and government/public health organisations.   Open Orphan runs challenge studies in London from both its 19-bedroom Whitechapel quarantine clinic, opened in February 2021, and its 24-bedroom QMB clinic which also has a highly specialised virology and immunology laboratory on-site. Open Orphan has a le...

Press release content from Business Wire. The AP news staff was not involved in its creation. Ethics Approval Granted for Open Orphan’s COVID-19 Human Challenge Study Model February 17, 2021 GMT LONDON--(BUSINESS WIRE)--Feb 17, 2021-- Open Orphan plc (AIM: ORPH), a rapidly growing specialist pharmaceutical services clinical research organisation (CRO) and world leader in vaccine and antiviral testing using human challenge clinical trials, announces the world’s first COVID-19 characterization study has received approval from a specially convened Research Ethics Committee (REC). This news f...